Product Dossier
DAKTARIN
Product Dossier for DAKTARIN (miconazole nitrate, Johnson & Johnson). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Johnson & Johnson
- Active ingredient: miconazole nitrate
- Therapeutic area: Dermatology
- Same area: DERMATANE
- Same area: NEOTIGASON
What it is
Daktarin is a brand of miconazole-containing medicines sponsored by Johnson & Johnson, available in multiple formulations including tincture, oral gel, powder, and cream preparations.
PBS listing
Daktarin cream containing miconazole nitrate 20 mg per g is available in two pack sizes: a 70 g tube listed on the PBS with streamlined restriction at an ex-manufacturer price of A$6.31, and a 30 g tube listed with streamlined restriction at A$5.16. The tincture formulation containing 20 mg per mL in a 30 mL bottle is PBS listed with streamlined restriction at an ex-manufacturer price of A$7.88. The powder containing miconazole nitrate 20 mg per g in a 30 g bottle is PBS listed with streamlined restriction at an ex-manufacturer price of A$5.65.
Regulatory history
Daktarin cream for athlete's foot, oral gel, tincture, and powder formulations were first listed on the ARTG on 28 August 1991. A pressurised spray formulation containing miconazole nitrate 20 mg per g was registered on the ARTG on 9 March 1995. A reformulated pressurised spray preparation containing miconazole nitrate 2% w/w was registered on 11 December 2025 under the restricted evaluation licence category.